|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 25/00 | (2006.01) |
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 1888100 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06763485.7 |
| Date of filing the European patent application | 2006-06-02 | |
| (97) | Date of publication of the European application | 2008-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2011-10-26 |
| (46) | Date of publication of the claims translation | 2011-12-27 |
| (86) | Number | PCT/EP2006/062864 |
| Date | 2006-06-02 |
| (87) | Number | WO 2006/128911 |
| Date | 2006-12-07 |
| (30) | Number | Date | Country code |
| 05104863 | 2005-06-03 | EP | |
| 688057 P | 2005-06-07 | US |
| (72) |
SAGOT, Yves, FR
CHVATCHKO, Yolande, CH
CORBAZ, Anne, CH
|
| (73) |
Merck Serono SA,
Centre Industriel, 1267 Coinsins, Vaud,
CH
|
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | IL-18BP izoformų panaudojimas neurologinių uždegiminių ligų gydymui ir/arba profilaktikai |
| USE OF IL-18BP ISOFORMS FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL INFLAMMATORY DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 20 | 347.00 EUR |